順威股份(002676.SZ):蔣九明被司法拍賣的4500萬股已流拍
格隆匯12月15日丨順威股份(002676.SZ)公佈,公司於2021年11月15日披露了《關於持股5%以上股東所持公司部分股份將被司法拍賣的提示性公吿》,合肥鐵路運輸法院於2021年12月14日上午10時至2021年12月15日上午10時止(延時除外)在淘寶網司法拍賣網絡平台進行網絡公開拍賣,拍賣公司持股5%以上股東蔣九明持有的順威股份4500萬股,佔公司總股本的6.25%,且全部處於質押/司法凍結狀態。根據淘寶網司法拍賣網絡平台顯示的拍賣結果,此次拍賣流拍。
根據2021年12月15日淘寶網司法拍賣網絡平台顯示的拍賣結果,此次網上拍賣無人報名參與競拍,此次拍賣已流拍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.